As a biotech entrepreneur, you are at the forefront of developing next-generation diagnostics, treatments, sustainable foods, and a range of other biobased products.
Eindhoven, The Netherlands, June 10th, 2024, UPyTher announces seed financing from Essential Investments, Brabant Development Agency (BOM) and TTT Medtech.
Groningen, 14th June, 2024 – ParaMedir proudly announces the award of approximately €1.8 million in European funding from the Just Transition Fund (JTF).
Europe’s healthtech sector is growing, and we’re all facing similar challenges. At the HealthTech Investor Summit, we bring together investors, innovators, mentors, and experts to help companies form the connections they need to flourish.
Six teams have started the Venture Challenge Spring 2024! Between 6 May and 28 June these starting lifesciences entrepreneurs will learn everything there is to know about building and pitching a businessplan.
ExoVectory in collaboration with UMC Utrecht, Utrecht University and EVerZom is awarded with the Eurostars grant - total value project €1,5Mio - for their innovative approach to developing an ex vivo engineered T-cell
The Venture Challenge Spring 2024 Kicked-off this week at Pivot Park. Six teams eager to bring their inventions to market joined us in the first 3-day bootcamp.
On 7 May 2024 a new application round of the Venture Challenge has opened. During the 10-week Venture Challenge program starting entrepreneurs in lifesciences are guided in developing their business plan and starting a company. The deadline for applying is 2 July, 2024 14:00.